Oxygen toxicity is reduced by acetylcholinesterase inhibition in the developing rat brain

Developmental Neuroscience

Volumn 35, Issue 2-3, 2013, Pages 255-264

  Sifringer, Marco ^a   Bendix, Ivo ^b   Von Haefen, Clarissa ^a   Endesfelder, Stefanie ^a   Kalb, Alexander ^a   Bührer, Christoph ^a   Felderhoff Mueser, Ursula ^b   Spies, Claudia D ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Acetylcholinesterase; Developing brain; Hyperoxia; Inflammation; Neurodegeneration; Oxidative stress

Indexed keywords

ACETYLCHOLINESTERASE; DONEPEZIL; GLUTATHIONE; INTERLEUKIN 1BETA; LIPID; MALONALDEHYDE; OXYGEN; PHYSOSTIGMINE; RNA; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRAIN DEVELOPMENT; CELL DEATH; CONFERENCE PAPER; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HYPEROXIA; LIPID PEROXIDATION; MALE; NERVE DEGENERATION; NEWBORN; NONHUMAN; OXIDATIVE STRESS; OXYGEN TOXICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WISTAR RAT;

EID: 84880214044     PISSN: 03785866     EISSN: 14219859     Source Type: Journal    
DOI: 10.1159/000346723     Document Type: Conference Paper

References (52)

1. Zhang XJ, Greenberg DS: Acetylcholinesterase involvement in apoptosis. Front Mol Neurosci 2012; 5: 40.
2. Jiang H, Zhang XJ: Acetylcholinesterase and apoptosis. A novel perspective for an old enzyme. FEBS J 2008; 275: 612-617.
3. Kaufer D, Friedman A, Seidman S, Soreq H: Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 1998; 393: 373-377.
4. Meshorer E, Erb C, Gazit R, Pavlovsky L, Kaufer D, Friedman A, Glick D, Ben-Arie N, Soreq H: Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science 2002; 295: 508-512.
5. Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ: Rethinking inflammation: neural circuits in the regulation of immunity. Immunol Rev 2012; 248: 188-204.
6. Grisaru D, Pick M, Perry C, Sklan EH, Almog R, Goldberg I, Naparstek E, Lessing JB, Soreq H, Deutsch V: Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol 2006; 176: 27-35.
7. Ofek K, Krabbe KS, Evron T, Debecco M, Nielsen AR, Brunnsgaad H, Yirmiya R, Soreq H, Pedersen BK: Cholinergic status modulations in human volunteers under acute inflammation. J Mol Med (Berl) 2007; 85: 1239-1251.
8. Toiber D, Berson A, Greenberg D, Melamed-Book N, Diamant S, Soreq H: N-acetylcholinesterase-induced apoptosis in Alzheimer's disease. PLoS One 2008; 3:e3108.
9. Zimmerman G, Soreq H: Termination and beyond: Acetylcholinesterase as a modulator of synaptic transmission. Cell Tissue Res 2006; 326: 655-669.
10. Tracey KJ: The inflammatory reflex. Nature 2002; 420: 853-859.
11. Shytle RD, Mori T, Townsend K, Vendrame M, Sun N, Zeng J, Ehrhart J, Silver AA, Sanberg PR, Tan J: Cholinergic modulation of microglial activation by alpha 7 nicotinic receptors. J Neurochem 2004; 89: 337-343.
12. Evron T, Moyal-Segal LB, Lamm N, Geffen A, Soreq H: RNA-targeted suppression of stressinduced allostasis in primate spinal cord neurons. Neurodegener Dis 2005; 2: 16-27.
13. Tyagi E, Agrawal R, Nath C, Shukla R: Cholinergic protection via alpha7 nicotinic acetylcholine receptors and PI3K-Akt pathway in LPS-induced neuroinflammation. Neurochem Int 2010; 56: 135-142.
14. Johnson S, Wolke D, Hennessy E, Marlow N: Educational outcomes in extremely preterm children: neuropsychological correlates and predictors of attainment. Dev Neuropsychol 2011; 36: 74-95.
15. Keller M, Felderhoff-Mueser U, Lagercrantz H, Dammann O, Marlow N, Huppi P, Buonocore G, Poets C, Simbruner G, Guimaraes H, Mader S, Merialdi M, Saugstad OD: Policy benchmarking report on neonatal health and social policies in 13 European countries. Acta Paediatr 2010; 99: 1624-1629.
16. Saugstad OD, Vento M, Ramji S, Howard D, Soll RF: Neurodevelopmental outcome of infants resuscitated with air or 100% oxygen: A systematic review and meta-analysis. Neonatology 2012; 102: 98-103.
17. Wright CJ, Dennery PA: Manipulation of gene expression by oxygen: A primer from bedside to bench. Pediatr Res 2009; 66: 3-10.
18. Felderhoff-Mueser U, Bittigau P, Sifringer M, Jarosz B, Korobowicz E, Mahler L, Piening T, Moysich A, Grune T, Thor F, Heumann R, Buhrer C, Ikonomidou C: Oxygen causes cell death in the developing brain. Neurobiol Dis 2004; 17: 273-282.
19. Schmitz T, Ritter J, Mueller S, Felderhoff-Mueser U, Chew LJ, Gallo V: Cellular changes underlying hyperoxia-induced delay of white matter development. J Neurosci 2011; 31: 4327-4344.
20. Sifringer M, Bendix I, Borner C, Endesfelder S, von Haefen C, Kalb A, Holifanjaniaina S, Prager S, Schlager GW, Keller M, Jacotot E, Felderhoff-Mueser U: Prevention of neonatal oxygen-induced brain damage by reduction of intrinsic apoptosis. Cell Death Dis 2012; 3:e250.
21. Sifringer M, Brait D, Weichelt U, Zimmerman G, Endesfelder S, Brehmer F, von Haefen C, Friedman A, Soreq H, Bendix I, Gerstner B, Felderhoff-Mueser U: Erythropoietin attenuates hyperoxia-induced oxidative stress in the developing rat brain. Brain Behav Immun 2010; 24: 792-799.
22. Sifringer M, Genz K, Brait D, Brehmer F, Lober R, Weichelt U, Kaindl AM, Gerstner B, Felderhoff-Mueser U: Erythropoietin attenuates hyperoxia-induced cell death by modulation of inflammatory mediators and matrix metalloproteinases. Dev Neurosci 2009; 31: 394-402.
23. Schmued LC: Demonstration and localization of neuronal degeneration in the rat forebrain following a single exposure to MDMA. Brain Res 2003; 974: 127-133.
24. Felderhoff-Mueser U, Sifringer M, Polley O, Dzietko M, Leineweber B, Mahler L, Baier M, Bittigau P, Obladen M, Ikonomidou C, Buhrer C: Caspase-1-processed interleukins in hyperoxia-induced cell death in the developing brain. Ann Neurol 2005; 57: 50-59.
25. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001; 25: 402-408.
26. Kaindl AM, Sifringer M, Zabel C, Nebrich G, Wacker MA, Felderhoff-Mueser U, Endesfelder S, von der Hagen M, Stefovska V, Klose J, Ikonomidou C: Acute and long-term proteome changes induced by oxidative stress in the developing brain. Cell Death Differ 2006; 13: 1097-1109.
27. Tuzun F, Kumral A, Ozbal S, Dilek M, Tugyan K, Duman N, Ozkan H: Maternal prenatal omega-3 fatty acid supplementation attenuates hyperoxia-induced apoptosis in the developing rat brain. Int J Dev Neurosci 2012; 30: 315-323.
28. Yis U, Kurul SH, Kumral A, Cilaker S, Tugyan K, Genc S, Yilmaz O: Hyperoxic exposure leads to cell death in the developing brain. Brain Dev 2008; 30: 556-562.
29. Hu T, Fu Q, Liu X, Zhang H, Dong M: Increased acetylcholinesterase and capase-3 expression in the brain and peripheral immune system of focal cerebral ischemic rats. J Neuroimmunol 2009; 211: 84-91.
30. Muthuraju S, Maiti P, Solanki P, Sharma AK, Amitabh, Singh SB, Prasad D, Ilavazhagan G: Acetylcholinesterase inhibitors enhance cognitive functions in rats following hypobaric hypoxia. Behav Brain Res 2009; 203: 1-14.
31. Cohen JE, Zimmerman G, Melamed-Book N, Friedman A, Dori A, Soreq H: Transgenic inactivation of acetylcholinesterase impairs homeostasis in mouse hippocampal granule cells. Hippocampus 2008; 18: 182-192.
32. Creeley CE, Wozniak DF, Nardi A, Farber NB, Olney JW: Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol Aging 2008; 29: 153-167.
33. Kutsuna S, Tsuruta R, Fujita M, Todani M, Yagi T, Ogino Y, Igarashi M, Takahashi K, Izumi T, Kasaoka S, Yuasa M, Maekawa T: Cholinergic agonist physostigmine suppresses excessive superoxide anion radical generation in blood, oxidative stress, early inflammation, and endothelial injury in rats with forebrain ischemia/reperfusion. Brain Res 2010; 1313: 242-249.
34. Myhrer T, Enger S, Aas P: Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents. Pharmacol Biochem Behav 2010; 95: 338-343.
35. Takada-Takatori Y, Kume T, Izumi Y, Ohgi Y, Niidome T, Fujii T, Sugimoto H, Akaike A: Roles of nicotinic receptors in acetylcholinesterase inhibitor-induced neuroprotection and nicotinic receptor up-regulation. Biol Pharm Bull 2009; 32: 318-324.
36. Zhao B, Moochhala SM, Tham SY: Biologically active components of physostigma venenosum. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 812: 183-192.
37. Lorke DE, Hasan MY, Nurulain SM, Shafiullah M, Kuca K, Petroianu GA: Pretreatment for acute exposure to diisopropylfluorophosphate: in vivo efficacy of various acetylcholinesterase inhibitors. J Appl Toxicol 2010, Epub ahead of print.
38. Hofer S, Eisenbach C, Lukic IK, Schneider L, Bode K, Brueckmann M, Mautner S, Wente MN, Encke J, Werner J, Dalpke AH, Stremmel W, Nawroth PP, Martin E, Krammer PH, Bierhaus A, Weigand MA: Pharmacologic cholinesterase inhibition improves survival in experimental sepsis. Crit Care Med 2008; 36: 404-408.
39. Racchi M, Mazzucchelli M, Porrello E, Lanni C, Govoni S: Acetylcholinesterase inhibitors: novel activities of old molecules. Pharmacol Res 2004; 50: 441-451.
40. Akasofu S, Kimura M, Kosasa T, Ogura H, Sawada K: Protective effect of donepezil in primary-cultured rat cortical neurons exposed to N-methyl-D-aspartate (NMDA) toxicity. Eur J Pharmacol 2006; 530: 215-222.
41. Akasofu S, Kosasa T, Kimura M, Kubota A: Protective effect of donepezil in a primary culture of rat cortical neurons exposed to oxygen-glucose deprivation. Eur J Pharmacol 2003; 472: 57-63.
42. Arias E, Gallego-Sandin S, Villarroya M, Garcia AG, Lopez MG: Unequal neuroprotection afforded by the acetylcholinesterase inhibitors galantamine, donepezil, and rivastigmine in SH-SY5y neuroblastoma cells: role of nicotinic receptors. J Pharmacol Exp Ther 2005; 315: 1346-1353.
43. Shen H, Kihara T, Hongo H, Wu X, Kem WR, Shimohama S, Akaike A, Niidome T, Sugimoto H: Neuroprotection by donepezil against glutamate excitotoxicity involves stimulation of alpha7 nicotinic receptors and internalization of NMDA receptors. Br J Pharmacol 2010; 161: 127-139.
44. Kotani S, Yamauchi T, Teramoto T, Ogura H: Donepezil, an acetylcholinesterase inhibitor, enhances adult hippocampal neurogenesis. Chem Biol Interact 2008; 175: 227-230.
45. Reale M, Iarlori C, Gambi F, Feliciani C, Salone A, Toma L, DeLuca G, Salvatore M, Conti P, Gambi D: Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the proinflammatory and anti-inflammatory cytokines. J Neuroimmunol 2004; 148: 162-171.
46. Hwang J, Hwang H, Lee HW, Suk K: Microglia signaling as a target of donepezil. Neuropharmacology 2010; 58: 1122-1129.
47. Tabet N: Acetylcholinesterase inhibitors for Alzheimer's disease: Anti-inflammatories in acetylcholine clothing! Age Ageing 2006; 35: 336-338.
48. Finkel T: Signal transduction by mitochondrial oxidants. J Biol Chem 2012; 287: 4434-4440.
49. Bhutada P, Mundhada Y, Bansod K, Tawari S, Patil S, Dixit P, Umathe S, Mundhada D: Protection of cholinergic and antioxidant system contributes to the effect of berberine ameliorating memory dysfunction in rat model of streptozotocin-induced diabetes. Behav Brain Res 2011; 220: 30-41.
50. Saxena G, Singh SP, Agrawal R, Nath C: Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocin-induced model of dementia in mice. Eur J Pharmacol 2008; 581: 283-289.
51. Shaked I, Meerson A, Wolf Y, Avni R, Greenberg D, Gilboa-Geffen A, Soreq H: Microrna-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity 2009; 31: 965-973.
52. Soreq H, Wolf Y: NeurimmiRs: microRNAs in the neuroimmune interface. Trends Mol Med 2011; 17: 548-555.